GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunic Inc (FRA:10VA) » Definitions » Unearned Premiums

Immunic (FRA:10VA) Unearned Premiums


View and export this data going back to 2014. Start your Free Trial

What is Immunic Unearned Premiums?

Unearned Premiums only applies to insurance companies.


Immunic Business Description

Traded in Other Exchanges
Address
1200 Avenue of the Americas, Suite 200, New York, NY, USA, 10036
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.